Studied protocol cards, and what they are not

• Studied protocol at the top, then the compound.
• The group or use the protocol was studied for, when a compound has more than one, and the route the source used.
• Source: the trial, label, or protocol the schedule comes from.
• Numbered phases, each with the dose, how often, and for how long, as the source describes them, and any notes.
• A research-only note underneath.

When a compound was studied in more than one way, you may see one card for each protocol.

• Not a plan for you. A trial's schedule was designed for its participants and monitored by its investigators. A community protocol has not been tested that way.
• Not personalized. The card is not adjusted for your age, weight, health, or medications.
• Not an endorsement. Showing a protocol does not mean ChatPEP considers it safe or effective.
• Not medical advice. Talk to a qualified healthcare provider before making any decision about a compound. See ChatPEP is not medical advice.

A card can appear when you ask how a compound was dosed or scheduled in the research. It is on every plan. The written answer beneath it explains what the source observed, why the schedule is structured the way it is, and how strong the evidence is.

• Check the source line. A named trial is different evidence from a community protocol. Ask ChatPEP for the study behind a card to see it cited.
• Compare the population. Note who was studied and for what. A schedule studied for one condition says little about another.
• Ask about the research. "Why did the doses rise between phases?" or "What side effects were reported in each phase?" are good follow-ups.
• Do the math separately. For concentration and volume, use the reconstitution calculator.

ChatPEP can make mistakes, including in a card. If a card does not match its source, select Report safety concern under the answer, or rate the answer with a thumbs down. See Rate an answer.